10-Q Filing

CVS HEALTH CORP CIK: 64803 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0000064803-20-000030`
Period End Date	20200630
Filing Date	20200805
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	a0630202010-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 80 Cash Flow Statement 78 Stockholders Equity 62 Comprehensive Income 38

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.87B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.68B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.37B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.60B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$19.62B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$22.52B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$16.52B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$17.52B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.11B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$6.00B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$50.30B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$62.51B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$17.31B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$18.59B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.31B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	425.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.04B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.22B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	425.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.57B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.86B	USD	Point-in-time
Goodwill	`Goodwill`	$80.06B	USD	Point-in-time
Goodwill	`Goodwill`	$79.75B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$33.12B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$32.23B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.64B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.46B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.68B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.60B	USD	Point-in-time
Total assets	`Assets`	$235.50B	USD	Point-in-time
Total assets	`Assets`	$222.45B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$10.49B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$9.92B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$13.60B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$15.54B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$7.36B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.88B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$3.64B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$2.99B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.13B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$15.63B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.83B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.64B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.77B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.60B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$8.19B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.78B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$53.30B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$63.69B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.93B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.61B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$64.70B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$63.48B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.14B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.29B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.64B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.46B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.44B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.27B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.16B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.31B	USD	Point-in-time
Total liabilities	`Liabilities`	$167.14B	USD	Point-in-time
Total liabilities	`Liabilities`	$158.28B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,732 shares issued and 1,307 shares outstanding at June 30, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$46.28B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,732 shares issued and 1,307 shares outstanding at June 30, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$45.97B	USD	Point-in-time
Treasury stock, at cost: 425 shares at both June 30, 2020 and December 31, 2019	`TreasuryStockValue`	$28.23B	USD	Point-in-time
Treasury stock, at cost: 425 shares at both June 30, 2020 and December 31, 2019	`TreasuryStockValue`	$28.23B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$48.77B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$45.11B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.02B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.21B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$63.86B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$68.02B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$333.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$306.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$235.50B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$222.45B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$32.07B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$34.57B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$15.79B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$16.93B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$346.00M	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$542.00M	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$293.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$184.00M	USD	1 Quarter
Total revenues	`Revenues`	$65.34B	USD	1 Quarter
Total revenues	`Revenues`	$132.10B	USD	2 Qtrs
Total revenues	`Revenues`	$125.08B	USD	2 Qtrs
Total revenues	`Revenues`	$63.43B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.24B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$76.22B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$38.97B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$80.59B	USD	2 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$11.75B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$13.09B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$26.14B	USD	2 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$26.55B	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$17.23B	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$16.29B	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$8.67B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.04B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$123.96B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$119.06B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$60.10B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$60.66B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$4.68B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.33B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$8.14B	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$6.02B	USD	2 Qtrs
Interest expense	`InterestExpense`	$765.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.50B	USD	2 Qtrs
Interest expense	`InterestExpense`	$772.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.55B	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$45.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$31.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$62.00M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$99.00M	USD	2 Qtrs
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.59B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$6.74B	USD	2 Qtrs
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.96B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$4.53B	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$660.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.17B	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$974.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.74B	USD	2 Qtrs
Net income	`ProfitLoss`	$5.00B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.99B	USD	1 Quarter
Net income	`ProfitLoss`	$1.93B	USD	1 Quarter
Net income	`ProfitLoss`	$3.36B	USD	2 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.00M	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.00M	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$4.98B	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$2.98B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$3.36B	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$1.94B	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$3.81	USD	2 Qtrs
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.49	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$2.58	USD	2 Qtrs
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$2.27	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.49	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.58	USD	2 Qtrs
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.26	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.79	USD	2 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	2 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	2 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	2 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$129.22B	USD	2 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$120.81B	USD	2 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$76.38B	USD	2 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$70.57B	USD	2 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$25.99B	USD	2 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$26.48B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$14.69B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$14.50B	USD	2 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$512.00M	USD	2 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$395.00M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$1.50B	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$1.41B	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$230.00M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.48B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.29B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.42B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.71B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.79B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$4.06B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$3.69B	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.29B	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.19B	USD	2 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$768.00M	USD	2 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$250.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-14.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-6.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.93B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.80B	USD	2 Qtrs
Net repayments of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	2 Qtrs
Net repayments of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-275.00M	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.95B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.90B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.02B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.31B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.31B	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$111.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$166.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$68.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$80.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$7.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-16.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.44B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.70B	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$9.19B	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.04B	USD	2 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.14B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.14B	USD	Point-in-time
Net income	`ProfitLoss`	$5.00B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.99B	USD	1 Quarter
Net income	`ProfitLoss`	$1.93B	USD	1 Quarter
Net income	`ProfitLoss`	$3.36B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.18B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.19B	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$179.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$226.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-101.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-42.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$681.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.23B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-1.00B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-939.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$314.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$560.00M	USD	2 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.67B	USD	2 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$917.00M	USD	2 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$-415.00M	USD	2 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$496.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$204.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.69B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.29B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.42B	USD	2 Qtrs

Stockholders Equity 62 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$2.99B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.43B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$2.01B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.93B	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$582.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$251.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$194.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$526.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$175.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$96.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$208.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$104.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-53.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-7.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$36.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$53.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$659.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$662.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$651.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$657.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-12.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$23.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time

Comprehensive Income 38 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$5.00B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.99B	USD	1 Quarter
Net income	`ProfitLoss`	$1.93B	USD	1 Quarter
Net income	`ProfitLoss`	$3.36B	USD	2 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$251.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$213.00M	USD	2 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$524.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$585.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$6.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-7.00M	USD	2 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-12.00M	USD	2 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	2 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$1.00M	USD	2 Qtrs
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$582.00M	USD	2 Qtrs
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$251.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$194.00M	USD	2 Qtrs
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$526.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.51B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.18B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.19B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.94B	USD	2 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.00M	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.00M	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$3.94B	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$2.19B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$5.18B	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$3.50B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.